Director Business Development

• Apr 2020 - Present

• Leading consultative BD for phI-IV trials and market access strategy in neurology. Services include detailed neurological patient characterisation through a fully integrated approach of AI-based MRI analysis, biomarker development, ePRO, EMR integration and predictive modelling• Closed >150% of 2020 target

VP Patient Engagement, lead icompanion

• Mar 2019 - Apr 2020

• Led the strategy, technical development, launch and BD of icompanion, the leading CE-marked patient application for people with MS, currently used by thousands of patients day-to-day, by HCPs in clinical practice, as well as in phIV clinical trials• As part of icometrix management, responsible for the icompanion business unit by monitoring business drivers, budget and operating metrics• Strategic pharma BD, KOL and patient organisation engagement

Director Business Development

• Apr 2018 - Mar 2019

• Pharma BD - as above• Led sales, marketing and distributor efforts in all non-US territories for icometrix' AI-based MRI-quantification portfolio to clinical practice in all non-US territories

Backpacking Asia

• Apr 2017 - Dec 2017

Associate Global Business Development and Licensing Neuroscience

• Jan 2017 - Mar 2017

• Developed recommendations for acquisition or licensing opportunities through conducting exhaustive search and evaluation of all (>150) drug programmes for two neurological/neuropsychiatric indications • Provided direct comparisons in terms of efficacy, tolerability, clinical trial designs and strategic fit with the Novartis neuroscience portfolio, as well as market/competitive trends, resulting in the setting up of a cross-functional group tasked to do further deep evaluation of the most promising assets

PhD

• Sep 2012 - Nov 2016

Thesis title: Grey matter pathology in multiple sclerosis: in vivo and post mortem magnetic resonance imaging studies • Awarded competitive PhD scholarship by the UK BBSRC• Structured, budgeted, launched, and drove various multiyear projects by developing hypotheses to gain insight into MS disease mechanisms, resulting in four articles published in leading scientific journals (including first author in Neurology and JNNP) and through poster presentations at four international conferences • Extracurricular business courses including London Business School MBA electives ‘Achieving Strategic Agility’ and ‘Managing Healthcare’, as well as courses on finance, leadership and management, and participated in the Engineering Young Entrepreneurs Scheme Competition (awarded Best team work award)

Honorary Research Assistant

• Feb 2012 - Aug 2012

• Conducted and published MRI study on grey matter pathology in Multiple Sclerosis• Awarded research grant by Dutch MS society and Prinses Beatrix Fonds• Awarded travel grant to give poster presentation at ECTRIMS (European MS conference)

Consultant

• Jun 2015 - Jul 2015

• Conducted exhaustive search and analysis of academic life-sciences spinouts, serial entrepreneurs and patent and therapeutic area trends in Europe and North America • Presented insights and comprehensive resource to top 5 pharma client’s BD&L team to allow client to identify new acquisition/licensing opportunities • Conducted exhaustive search and analysis of academic life-sciences spinouts, serial entrepreneurs and patent and therapeutic area trends in Europe and North America • Presented insights and comprehensive resource to top 5 pharma client’s BD&L team to allow client to identify new acquisition/licensing opportunities

Medical and Marketing Intern

• Jan 2015 - Apr 2015

• Identified best approach to quantify MRI biomarkers in clinical practice, through conducting interviews with CEOs and KOLs, aimed to enrich prescription decision-making based with additional objective clinical data, in line with Teva’s marketing and medical objectives• Created a comprehensive overview comparing all global MS patient registries to gain real world evidence on Teva’s CNS therapies • Identified best approach to quantify MRI biomarkers in clinical practice, through conducting interviews with CEOs and KOLs, aimed to enrich prescription decision-making based with additional objective clinical data, in line with Teva’s marketing and medical objectives• Created a comprehensive overview comparing all global MS patient registries to gain real world evidence on Teva’s CNS therapies

PhD placement

• Oct 2012 - Jan 2013

• Studied the role of mitophagy in cellular degeneration using various microscopy, molecular biology and biochemistry techniques • Studied the role of mitophagy in cellular degeneration using various microscopy, molecular biology and biochemistry techniques

Research Intern

• Feb 2011 - Jul 2011

• Conducted PET study on microglia activation in Alzheimer's disease • Conducted PET study on microglia activation in Alzheimer's disease

Research Assistant at Center for the Study of Human Cognition

• Sep 2008 - Jun 2010

• Awarded research grant by Norwegian Research Council• Researched systems of attention, using pupillometry and fMRI and resented results inoral conference presentation and co-authored paper • Awarded research grant by Norwegian Research Council• Researched systems of attention, using pupillometry and fMRI and resented results inoral conference presentation and co-authored paper